Latest Posts › China

Share:

Top legal issues to think about in China-related licensing transactions

This article provides a general overview of certain Chinese legal considerations for licensing and collaboration deals in the life sciences industry. In particular, this article focuses on two types of transactions...more

China update: Human Genetic Resources Administration Rules support HGR Implementing Rules

After years of waiting, China’s Ministry of Science and Technology (MOST) finally released the final version of the Implementing Rules on the Human Genetic Resources Administration Rules (Implementing Rules) on 1 June 2023,...more

JPM2024: Impact of China’s HGR Rules on clinical trials and scientific studies involving China sites

Life sciences companies engaged in early development programs face a number of strategic considerations, such as where and how to administer the early stage scientific studies and each phase of clinical trials that are needed...more

Spotlight on Greater China: antitrust and regulatory risks in life sciences distribution channels

As part of a new Asia-Pacific (APAC) Life Sciences and Health Care webinar program designed both for companies with commercial interests in APAC and for companies based in the region, Hogan Lovells is hosting a special...more

China's draft implementation rules on human genetic resources: potential changes on HGR Supervision?

The Ministry of Science and Technology of China has finally issued the draft of Implementation Rules for the Regulations of Human Genetic Resources Administration for public comments on March 21, 2022, which gives more...more

China’s first personal information protection law in the home stretch

On 29 April, China’s National People’s Congress released the second consultation draft of the Personal Information Protection Law (New PIPL Draft). Public comments are open through 28 May 2021. The first draft of the Personal...more

China takes a pragmatic approach to relaxing regulation of the life sciences sector during COVID-19

As the coronavirus (COVID-19) spreads across the world, creating new epicenters, this is perhaps an opportune moment to look back at the lessons learned from China, where it appears that the outbreak is under control, in...more

Third party payment licences in China – are they within the grasp of foreign investors?

China is marching on to be the world's pioneering cashless society but unfortunately there is an almost complete absence of foreign counterparts in the huge Chinese domestic or cross border transactions initiated from China....more

China's first data protection measures lifting its veils

On 28 May 2019, the Cyberspace Administration of China (CAC) released the draft Measures on the Administration of Data Security (Data Security Measures, see our in-house English translation here) for public...more

China marches into cybersecurity classified protection 2.0 - May 2019

The cybersecurity classified protection regime attracted significant attention when it was included in the Peoples Republic of China (PRC) Cyber Security Law promulgated in 2017 (the CSL). The CSL mandates that network...more

A comparison of IoT regulatory uncertainty in the EU, China, and the United States

A Hogan Lovells study comparing regulatory requirements in the European Union, China, and the United States shows the complexity and uncertainty of the regulatory framework relevant to Internet of Things (IoT) in Europe. ...more

Busting the Myth: Compliance with the ‘Gold Standard’ of the GDPR Does Not Buy You a ‘Free Pass’ Under China’s New Personal...

On December 29, 2017, the Standardization Administration of China, jointly with the PRC General Administration of Quality Supervision, Inspection and Quarantine, issued the Information Security Technology – Personal...more

China’s new rules on telemedicine and Internet hospitals - some things clarified, some questions left unanswered

China's new rules for Internet-based medical services – telemedicine, Internet hospitals and Internet-based diagnosis came into force on 17 July 2018. ...more

New scientific data rules in China: China claims "data sovereignty"

In March of this year, the State Council released the Scientific Data Administrative Measures, a set of rules with the seemingly innocuous aim of collecting and making public the results of government-funded scientific...more

PBOC opens the door for foreign payment institutions

On March 21, 2018, the Chinese central bank and regulator of payment services operators (“PSOs“), the People’s Bank of China (the “PBOC“) circulated PBOC Announcement No.7 of 2018 (the “Announcement“) lifting the de facto but...more

The China Food and Drug Administration pushes forward on conditional approval and compassionate use of new drugs

On December 20, 2017, the China Food and Drug Administration (“CFDA“) released two draft documents for public comment: (1) Conditional Approval for Urgently Needed Drugs Technical Guidance (the “Draft Conditional Approval...more

16 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide